Showing 1,021 - 1,040 results of 99,809 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 1.33s Refine Results
  1. 1021
  2. 1022

    VGB treatment decreased the number of GFAP positive cells in hippocampus of <i>Tsc1</i><sup>GFAP</sup>CKO mice. by Bo Zhang (6559)

    Published 2013
    “…(B) Quantitative analysis demonstrated a 2–2.5 fold increase in GFAP-positive cell in vehicle-treated <i>Tsc1</i><sup>GFAP</sup>CKO group (KO + Veh) compared with vehicle-treated control group (Cont + Veh) in neocortex (CT), dentate gyrus (DG) and CA1 of hippocampus. …”
  3. 1023
  4. 1024
  5. 1025

    Attenuation of spheroid size decrease or MUC5AC increase by hit compounds. by Pranjali Beri (14945400)

    Published 2023
    “…<p>Final hit compounds (with hit concentration and corresponding target) that <b>A)</b> increased bronchosphere size compared to DMSO + 3% CSE control bronchospheres or <b>B)</b> decreased secreted MUC5AC. …”
  6. 1026

    Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

    Published 2014
    “…<p>(A) Turnover rates, as measured by 5-HIAA:5-HT ratios, normalized to the values of vehicle-treated animals, for the following drugs: fluoxetine (FLX; chronic treatment with 10 mg/kg); chlordiazepoxide (CDZ; 0.02 mg/kg); clonazepam (CLZ; 0.05 mg/kg); diazepam (DZP; 1.25 mg/kg); buspirone (BUS; 50 mg/kg); ethanol (EtOH, 2.5%); dizocilpine (MK; 0.005 mg/kg); verapamil (VER; 5 mg/kg); WAY 100,635 (WAY; 0.03 mg/kg); and SB 224,289 (SB; 2.5 mg/kg). …”
  7. 1027
  8. 1028

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
  9. 1029
  10. 1030
  11. 1031
  12. 1032
  13. 1033
  14. 1034
  15. 1035

    Wounds treated with sDll4-Fc have increased vascular density but decreased vascular maturation in direct proportion to the dosage level. by Alexandre Trindade (187498)

    Published 2012
    “…B) Vascular smooth muscle cell coverage is decreased about 3-fold in relation to PBS-injected control mice throughout the experimental days in both tested groups. …”
  16. 1036
  17. 1037
  18. 1038
  19. 1039
  20. 1040